187 results
8-K
EX-99.1
LGND
Ligand Pharmaceuticals, Inc. - Ordinary Shares
7 May 24
Ligand Reports First Quarter 2024 Financial Results
4:03pm
for the additional investment.
On April 3, Ligand announced the creation of Pelthos Therapeutics under the leadership of Scott Plesha as Chief Executive
8-K
jtkbm4
4 Nov 22
Unaudited Pro Forma Condensed Consolidated Financial Statements
4:08pm
425
EX-99.1
houm g8izm7k69eux6
21 Jun 22
Business combination disclosure
8:00am
8-K
EX-99.1
7bvv6kabroqf xmw2
21 Jun 22
Regulation FD Disclosure
6:19am
425
EX-99.3
2g33b0d nm7yzg5latg
23 Mar 22
Business combination disclosure
5:29pm
425
EX-99.1
pdjhq587ogjj7g0rd
23 Mar 22
Business combination disclosure
5:29pm
425
EX-99.2
gezqyiq ehaqyxgv99p
23 Mar 22
Business combination disclosure
5:29pm
8-K
EX-99.1
qizesz09gfckrzpep0
23 Mar 22
Ligand to Spin-Off its OmniAb Business Through Merger with Avista Public Acquisition Corp. II
5:25pm
8-K
EX-99.2
2cpuvmyd6 uznpuo7k
23 Mar 22
Ligand to Spin-Off its OmniAb Business Through Merger with Avista Public Acquisition Corp. II
5:25pm
8-K
EX-99.3
z7axxhkrvxkc18y35
23 Mar 22
Ligand to Spin-Off its OmniAb Business Through Merger with Avista Public Acquisition Corp. II
5:25pm